Literature DB >> 29496994

Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.

Tomio Matsumura1,2,3, Shigeaki Hida4, Masato Kitazawa3, Chifumi Fujii1,5, Akira Kobayashi3, Michiko Takeoka3, Shun-Ichiro Taniguchi1, Shin-Ichi Miyagawa6.   

Abstract

Fascin1 is an actin-bundling protein involved in cancer cell migration and has recently been shown also to have roles in virus-mediated immune cell responses. Because viral infection has been shown to activate immune cells and to induce interferon-β expression in human cancer cells, we evaluated the effects of fascin1 on virus-dependent signaling via the membrane- and actin-associated protein RIG-I (retinoic acid-inducible gene I) in colon cancer cells. We knocked down fascin1 expression with shRNA retrovirally transduced into a DLD-1 colon cancer and L929 fibroblast-like cell lines and used luciferase reporter assays and co-immunoprecipitation to identify fascin1 targets. We found that intracellular poly(I·C) transfection to mimic viral infection enhances the RIG-I/MDA5 (melanoma differentiation-associated gene 5)-mediated dimerization of interferon regulatory factor 3 (IRF-3). The transfection also significantly increased the expression levels of IRF-7, interferon-β, and interferon-inducible cytokine IP-10 in fascin1-deleted cells compared with controls while significantly suppressing cell growth, migration, and invasion. We also found that fascin1 constitutively interacts with IκB kinase ϵ (IKKϵ) in the RIG-I signaling pathway. In summary, we have identified fascin1 as a suppressor of the RIG-I signaling pathway associating with IκB kinase ϵ in DLD-1 colon cancer cells to suppress immune responses to viral infection.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  IκB Kinase ϵ fascin1; RIG-I-like receptor (RLR); interferon; interferon regulatory factor (IRF); invasion; poly(I·C); signal transducers and activators of transcription 1 (STAT1)

Mesh:

Substances:

Year:  2018        PMID: 29496994      PMCID: PMC5925820          DOI: 10.1074/jbc.M117.819201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.

Authors:  Mirko Trilling; Vu Thuy Khanh Le; Jassin Rashidi-Alavijeh; Benjamin Katschinski; Jürgen Scheller; Stefan Rose-John; Gabriela Elena Androsiac; Stipan Jonjic; Valeria Poli; Klaus Pfeffer; Hartmut Hengel
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

2.  Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.

Authors:  Sara Palchetti; Donatella Starace; Paola De Cesaris; Antonio Filippini; Elio Ziparo; Anna Riccioli
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

3.  Fascin expression is increased in metastatic lesions but does not correlate with progression nor outcome in melanoma.

Authors:  Yafeng Ma; William J Faller; Owen J Sansom; Ewan R Brown; Tamasin N Doig; David W Melton; Laura M Machesky
Journal:  Melanoma Res       Date:  2015-04       Impact factor: 3.599

4.  Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

Authors:  Robert Besch; Hendrik Poeck; Tobias Hohenauer; Daniela Senft; Georg Häcker; Carola Berking; Veit Hornung; Stefan Endres; Thomas Ruzicka; Simon Rothenfusser; Gunther Hartmann
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

5.  IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response.

Authors:  Junjie Zhang; Hao Feng; Jun Zhao; Emily R Feldman; Si-Yi Chen; Weiming Yuan; Canhua Huang; Omid Akbari; Scott A Tibbetts; Pinghui Feng
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

6.  Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain.

Authors:  Iwona Sadzak; Melanie Schiff; Irene Gattermeier; Reingard Glinitzer; Ines Sauer; Armin Saalmüller; Edward Yang; Barbara Schaljo; Pavel Kovarik
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

7.  RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.

Authors:  P Duewell; A Steger; H Lohr; H Bourhis; H Hoelz; S V Kirchleitner; M R Stieg; S Grassmann; S Kobold; J T Siveke; S Endres; M Schnurr
Journal:  Cell Death Differ       Date:  2014-07-11       Impact factor: 15.828

8.  Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions.

Authors:  Amitava Mukherjee; Stefanie A Morosky; Le Shen; Christopher R Weber; Jerrold R Turner; Kwang Sik Kim; Tianyi Wang; Carolyn B Coyne
Journal:  J Biol Chem       Date:  2009-01-03       Impact factor: 5.157

9.  Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Authors:  Min-Jung Kim; Sun-Young Hwang; Tadaatsu Imaizumi; Joo-Yeon Yoo
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

10.  Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis.

Authors:  Yosuke Hashimoto; Maddy Parsons; Josephine C Adams
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

View more
  8 in total

1.  MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung.

Authors:  Kazuhiro Yamanoi; Chifumi Fujii; Hanae Yuzuriha; Mai Kumazawa; Masayuki Shimoda; Katsura Emoto; Hisao Asamura; Jun Nakayama
Journal:  Histochem Cell Biol       Date:  2022-03-30       Impact factor: 4.304

2.  Network-based identification of biomarkers for colon adenocarcinoma.

Authors:  Fuyan Hu; Qing Wang; Zhiyuan Yang; Zeng Zhang; Xiaoping Liu
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

Review 3.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.

Authors:  Kiramage Chathuranga; Asela Weerawardhana; Niranjan Dodantenna; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2021-11-16       Impact factor: 8.718

4.  Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.

Authors:  Haizhou Wang; Yabo Zhou; Yangyang Zhang; Shilin Fang; Meng Zhang; Haiou Li; Fei Xu; Lan Liu; Jing Liu; Qiu Zhao; Fan Wang
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

5.  Immune Tolerance vs. Immune Resistance: The Interaction Between Host and Pathogens in Infectious Diseases.

Authors:  Hafiz Ishfaq Ahmad; Abdul Jabbar; Nadia Mushtaq; Zainab Javed; Muhammad Umar Hayyat; Javaria Bashir; Iqra Naseeb; Zain Ul Abideen; Nisar Ahmad; Jinping Chen
Journal:  Front Vet Sci       Date:  2022-03-29

6.  Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer.

Authors:  Lingling Lu; Huaxiang Wang; Jian Fang; Jiaolong Zheng; Bang Liu; Lei Xia; Dongliang Li
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

Review 7.  Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor.

Authors:  Begoña Alburquerque-González; Fernando F López-Calderón; María Dolores López-Abellán; Ángel Esteban-Gil; José García-Solano; Pablo Conesa-Zamora
Journal:  Int J Mol Sci       Date:  2020-03-14       Impact factor: 5.923

8.  The RNA binding protein Quaking represses splicing of the Fibronectin EDA exon and downregulates the interferon response.

Authors:  Kuo-Chieh Liao; Vanessa Chuo; W Samuel Fagg; Cassandra M Modahl; Steven Widen; Mariano A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.